Treatment of cerebral vasospasm with cilostazol in subarachnoid haemorrhage model


Bilginer B., Onal B., Yigitkanli K., Soeylemezoglu F., Bavbek M., Ziyal L. M., ...More

9th International Conference on Cerebral Vasospasm, İstanbul, Turkey, 27 - 30 June 2006, vol.104, pp.291-293 identifier identifier

  • Publication Type: Conference Paper / Full Text
  • Volume: 104
  • Doi Number: 10.1007/978-3-211-75718-5_60
  • City: İstanbul
  • Country: Turkey
  • Page Numbers: pp.291-293
  • Hacettepe University Affiliated: Yes

Abstract

Background. Vasospasm is still an important cause of morbidity and mortality following subarachnoid haemorrhage (SAH). The current study was, undertaken to determine whether cilostazol therapy reverses vasospasm.